Suche

9766 Treffer – Seite 496 von 814

Implications of Tricuspid Regurgitation and Right Ventricular Volume Overload in Patients with Heart Failure with Preserved Ejection Fraction - HERACLES-HFpEF

Real-time Cardiovascular Magnetic Resonance Imaging for Non-Invasive Characterisation of Heart Failure with Preserved Ejection Fraction: Final Outcomes of the HFpEF Stress Trial

Prognostic Significance of NT-proBNP, NYHA Classification and Comorbidities in Acute Heart Failure: Insights from a Large-Scale Study of 24,097 cases

Prediction of microvascular obstruction at cardiac magnetic resonance after myocardial infarction based on high-sensitivity cardiac troponin T levels

Real-World Evidence from an Emulated Randomized Controlled Trial Supports Superior Efficacy of Prasugrel over Ticagrelor in Acute Coronary Syndromes

Clonal hematopoiesis of indeterminate potential (CHIP) affects cardiovascular disease severity via pro-inflammatory myeloid cells without increased plaque-side accumulation

Aspirin and heparin pretreatment in STEMI following 2023 ESC guideline update - a propensity score matched analysis from a metropolitan STEMI registry

The Prognostic Impact of Tricuspid Regurgitation Improvement after Left-sided Valvular Interventions

Outcomes beyond 10 years of transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis

Impact of post-procedural residual mitral regurgitation and mean gradient on outcomes following TEER for primary mitral regurgitation: Insights from the PRIME-MR Registry

Rechtsventrikuläre Dysfunktion und beeinträchtigtes RV–PA Coupling bei paradoxer low-flow, low-gradient Aortenklappenstenose

Transcatheter mitral valve-in-ring implantation with LVOT obstruction after failed LAMPOON – Limitations of the transcatheter valve-in-ring procedure

1
...
490
491
492
493
494
495
496
497
498
499
500
510
520
530
540
550
560
570
580
590
600
700
800
...
814

Das Portal für Herzmedizin und Herzgesundheit.

Betrieben von der HKM - Herz-Kreislauf-Medizin gGmbH

*Jeder Förderer unterstützt Herzmedizin.de mit 150.000 Euro jährlich. Die Förderer haben keinerlei Einfluss auf die Themengestaltung und die redaktionellen Inhalte des Portals.